Dr. Jack Charles Burns Ii, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 Brooks St Ste 200, Charleston, WV 25301 Phone: 304-388-1930 Fax: 304-388-1929 |
Matthew Beasley, Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 3200 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-388-8199 |
Ali Caroline Maitland, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1220 Lee St E Ste 208, Charleston, WV 25301 Phone: 304-388-7220 |
Dr. Samuel C Rossi, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 Tracy Way, Suite 2, Charleston, WV 25311 Phone: 304-388-4965 Fax: 304-388-4968 |
Dr. Bryan K Richmond, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1201 Washington Street, E, Suite 103, Charleston, WV 25301 Phone: 304-388-7270 Fax: 304-388-7280 |
News Archive
Following a successful funding application, staff at the University of Manchester, Wellcome Trust Centre for Cell Matrix Research, have become the proud owners of a Livecyte Cell Imaging & Analysis System.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for schizophrenia in the transgenic chakragati (ckr) model of psychosis. The mouse model screening was performed by the Contract Research Organization, Cerca Insights.
As we try to get outside and make the most of these cold winter months, it's important to use basic safety tips that help minimize injury. The Minnesota Chiropractic Association (MCA) offers the following tips to help keep your family injury free.
Spontaneous brain activity formerly thought to be "white noise" measurably changes after a person learns a new task, researchers at Washington University School of Medicine in St. Louis and the University of Chieti, Italy, have shown.
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
› Verified 6 days ago